Established in 2013, cmonet was originally created for large pharmaceutical organizations in response to rising regulatory expectations and expanding accountability of the CMO role. As these pressures have intensified and are often more acute in small and mid sized biopharma, cmonet is now expanding to serve SMB CMOs, recognizing their broader remit, leaner teams, and direct exposure to regulators and investors. 

This roundtable will explore:

• How organizations implement lean medical governance and clinical development leadership
• How SMB CMOs are adapting governance, safety, and evidence strategies to deliver decisions fast with lean teams
• Key priorities and emerging themes shaping the next 5 years.

Who Should Attend

• Chief Medical Officers
• Medical Governance Leads
• Senior leaders from emerging biotech and mid-sized pharma companies

If you would like more information about this virtual roundtable, please complete the adjacent form, and a member of our networks team will be in touch.

© 2026 Navitas Life Sciences | Privacy Policy